Skip to main content
SpringerLink
Log in

BK Polyomavirus After Solid Organ and Hematopoietic Cell Transplantation: One Virus – Three Diseases

  • Living reference work entry
  • First Online:
Emerging Transplant Infections

Abstract

Polyomavirus-associated nephropathy (PyVAN) and hemorrhagic cystitis (PyVHC) occur almost exclusively after kidney transplantation (KT) and allogeneic hematopoietic stem cell transplantation (HSCT), respectively. In addition, PyV-associated urothelial cancer (PyVUC) is emerging after KT. These diseases are attributed to BK polyomavirus (BKPyV), a small non-enveloped, double-stranded DNA virus infecting >90% of the general population followed by renal persistence. PyVAN causes premature allograft failure in 1–15% of KT, while PyVHC complicates 5–25% of allogeneic HSCT with excess morbidity. PyVUC is currently diagnosed in <1% of KT but impacts graft and patient survival. Insufficient antiviral immunity post-transplant is key to extensive replicative cytopathic damage seen in PyVAN and PyVHC by epithelial denudation, inflammation, and fibrotic scarring while permitting genetic accidents including chromosomally integrated viral genomes in PyVUC. However, immunosuppression alone is not sufficient since heart and lung transplant recipients are rarely affected despite more intense immunosuppression. Specific cofactors have been postulated in addition to the allogeneic constellation between the BKPyV-replicating host cell and the respective immune effectors. In KT, a mismatch between a high renal BKPyV load in the transplant and a low number of recipient immune effector functions is proposed in addition to tacrolimus, mycophenolate, and steroids. In allogeneic HSCT, bladder-toxic conditioning, e.g., by cyclophosphamide, is proposed to cause subclinical rarefication of the bladder urothelium, which becomes clinically overt by high-level BKPyV replication and inflammatory exacerbation post-engraftment. Long-standing failure to resume immune control may allow for genetic replicative accidents and outgrowth of PyVUC. In PyVAN and PyVHC, high-level viruria and plasma BKPyV-DNAemia correlate with disease activity and could assist in developing antiviral drugs currently lacking. Early stepwise reduction of immunosuppression is recommended in KT, an option severely limited in PyVHC by imminent graft-versus-host disease. Phase I/II study results are awaited investigating mTOR (mechanistic target of rapamycin) inhibitors, low-dose cyclosporine, leflunomide, intravenous immunoglobulin, monoclonal antibodies, and T-cell therapy. Until then, PyVAN, PyVHC, and PyVUC will continue to represent significant unmet clinical needs in transplant medicine jeopardizing otherwise successful outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Abudayyeh A, Hamdi A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Salahudeen A, Oran B, Chemaly RF, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Winkelmayer WC, Rezvani K. Symptomatic BK virus infection is associated with kidney function decline and poor overall survival in allogeneic hematopoietic stem cell recipients. Am J Transplant. 2016;16:1492–502.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Arthur RR, Shah KV, Charache P, Saral R. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis. 1988;158:563–9.

    Article  PubMed  CAS  Google Scholar 

  3. Barber CE, Hewlett TJ, Geldenhuys L, Kiberd BA, Acott PD, Hatchette TF. BK virus nephropathy in a heart transplant recipient: case report and review of the literature. Transpl Infect Dis. 2006;8:113–21.

    Article  PubMed  CAS  Google Scholar 

  4. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, Arthur RR, Jones RJ. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol. 1995;13:1103–9.

    Article  PubMed  CAS  Google Scholar 

  5. Bernhoff E, Gutteberg TJ, Sandvik K, Hirsch HH, Rinaldo CH. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am J Transplant. 2008;8:1413–22.

    Article  PubMed  CAS  Google Scholar 

  6. Binet I, Nickeleit V, Hirsch HH, Prince O, Dalquen P, Gudat F, Mihatsch MJ, Thiel G. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999;67:918–22.

    Article  PubMed  CAS  Google Scholar 

  7. Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Curr Opin Organ Transplant. 2000;5:210–6.

    Article  Google Scholar 

  8. Bischof N, Hirsch HH, Wehmeier C, Amico P, Dickenmann M, Hirt-Minkowski P, Steiger J, Menter T, Hopfer H, Schaub S. Reducing calcineurin inhibitor-first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes. Nephrol Dial Transplant. 2019 Jul. 1;34(7):1240–1250.

    Article  Google Scholar 

  9. Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, Torrence S, Schuessler R, Roby T, Gaudreault-Keener M, Storch GA. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5:582–94.

    Article  PubMed  CAS  Google Scholar 

  10. Cesaro S, Tridello G, Pillon M, Calore E, Abate D, Tumino M, Carucci N, Varotto S, Cannata E, Pegoraro A, Barzon L, Palu G, Messina C. A prospective study on the predictive value of plasma BK virus-DNA load for hemorrhagic cystitis in pediatric patients after stem cell transplantation. J Pediatric Infect Dis Soc. 2015;4:134–42.

    Article  PubMed  Google Scholar 

  11. Cesaro S, Dalianis T, Rinaldo CH, Koskenvuo M, Pegoraro A, Einsele H, Cordonnier C, Hirsch HH, Ecil- Group. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother. 2018;73:12–21.

    Article  PubMed  CAS  Google Scholar 

  12. D’Souza A, Fretham C. CIBMTR summary slides 2018: current uses and outcomes of hematopoietic cell transplantation (HCT). 43. 2018. https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx

  13. Dalianis T, Hirsch HH. Chapter 16: BK polyomavirus and transformation. In: Robertson ES, Perelmann School of Medicine, Philadelphia University of Pennsylvania, PA, USA and erle@upenn.edu, editors. Cancer associated viruses. Springer Sciences & Business Media. New York, NY 10013, USA. 2012.

    Google Scholar 

  14. Dalianis T, Hirsch HH. Human polyomaviruses in disease and cancer. Virology. 2013;437:63–72.

    Article  PubMed  CAS  Google Scholar 

  15. Dharnidharka VR, Cherikh WS, Neff R, Cheng Y, Abbott KC. Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis. Am J Transplant. 2010;10:1312–5.

    Article  PubMed  CAS  Google Scholar 

  16. Drachenberg CB, Beskow CO, Cangro CB, Bourquin PM, Simsir A, Fink J, Weir MR, Klassen DK, Bartlett ST, Papadimitriou JC. Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol. 1999;30:970–7.

    Article  PubMed  CAS  Google Scholar 

  17. Drachenberg CB, Papadimitriou JC, Hirsch HH, Wali R, Crowder C, Nogueira J, Cangro CB, Mendley S, Mian A, Ramos E. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant. 2004;4:2082–92.

    Article  PubMed  Google Scholar 

  18. Drachenberg CB, Hirsch HH, Papadimitriou JC, Gosert R, Wali RK, Munivenkatappa R, Nogueira J, Cangro CB, Haririan A, Mendley S, Ramos E. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84:323–30.

    Article  PubMed  Google Scholar 

  19. Drachenberg CB, Papadimitriou JC, Chaudhry MR, Ugarte R, Mavanur M, Thomas B, Cangro C, Costa N, Ramos E, Weir MR, Haririan A. Histological evolution of BK virus-associated nephropathy: importance of integrating clinical and pathological findings. Am J Transplant. 2017;17:2078–91.

    Article  PubMed  CAS  Google Scholar 

  20. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199:837–46.

    Article  PubMed  CAS  Google Scholar 

  21. Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D, Davis C, Boeckh M. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood. 2005;106:1130–2.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–100.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Funk GA, Steiger J, Hirsch HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis. 2006;193:80–7.

    Article  PubMed  Google Scholar 

  24. Funk GA, Gosert R, Comoli P, Ginevri F, Hirsch HH. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant. 2008;8:2368–77.

    Article  PubMed  CAS  Google Scholar 

  25. Gaziev J, Paba P, Miano R, Germani S, Sodani P, Bove P, Perno CF, Marziali M, Gallucci C, Isgro A, Paciaroni K, Roveda A, Simone MD, De Angelis G, Alfieri C, Lucarelli G. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol Blood Marrow Transplant. 2010;16:662–71.

    Article  PubMed  CAS  Google Scholar 

  26. Geetha D, Sozio SM, Ghanta M, Josephson M, Shapiro R, Dadhania D, Hariharan S. Results of repeat renal transplantation after graft loss from BK virus nephropathy. Transplantation. 2011;92:781–6.

    Article  PubMed  Google Scholar 

  27. Gilis L, Morisset S, Billaud G, Ducastelle-Lepretre S, Labussiere-Wallet H, Nicolini FE, Barraco F, Detrait M, Thomas X, Tedone N, Sobh M, Chidiac C, Ferry T, Salles G, Michallet M, Ader F. High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2014;49:664–70.

    Article  PubMed  CAS  Google Scholar 

  28. Giraud G, Priftakis P, Bogdanovic G, Remberger M, Dubrulle M, Hau A, Gutmark R, Mattson J, Svahn BM, Ringden O, Winiarski J, Ljungman P, Dalianis T. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts. Bone Marrow Transplant. 2008;41:737–42.

    Article  PubMed  CAS  Google Scholar 

  29. Greenlee JE, Hirsch HH. Polyomaviruses. In: ASM American Society for Microbiology, editor. Clinical virology. 4th ed. Washington, DC: ASM Press; 2017. (asmscience.org).

    Google Scholar 

  30. Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med. 1953;83:414–21.

    Article  PubMed  CAS  Google Scholar 

  31. Han TT, Xu LP, Liu DH, Liu KY, Fu HX, Zhao XY, Zhao XS, Huang XJ. Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2014;89:55–61.

    Article  PubMed  CAS  Google Scholar 

  32. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant. 2010;10:407–15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Hill JA, Mayer BT, Xie H, Leisenring WM, Huang ML, Stevens-Ayers T, Milano F, Delaney C, Sorror ML, Sandmaier BM, Nichols G, Zerr DM, Jerome KR, Schiffer JT, Boeckh M. The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality. Blood. 2017;129:2316–25.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Hirsch HH. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant. 2002;2:25–30.

    Article  PubMed  Google Scholar 

  35. Hirsch HH. Human polyomavirus and papillomavirus infection and disease posttransplant. In: Ljungman P, Snydman D, editors. Transplant infections. Cham: Springer; 2016.

    Google Scholar 

  36. Hirsch HH, Ramos E. Retransplantation after polyomavirus-associated nephropathy: just do it? Am J Transplant. 2006;6:7–9.

    Article  PubMed  CAS  Google Scholar 

  37. Hirsch HH, Randhawa PS. Screening for BK polyomavirus DNAemia: what should be done? Clin Transplant. 2019;33:e13672.

    PubMed  Google Scholar 

  38. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347:488–96.

    Article  PubMed  Google Scholar 

  39. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis. 2004;38:1159–66.

    Article  PubMed  Google Scholar 

  40. Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, Mihatsch MJ, Nickeleit V, Ramos E, Randhawa P, Shapiro R, Steiger J, Suthanthiran M, Trofe J. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79:1277–86.

    Article  PubMed  Google Scholar 

  41. Hirsch HH, Kardas P, Kranz D, Leboeuf C. The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS. 2013; 121:685–727.

    Article  PubMed  CAS  Google Scholar 

  42. Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, Scheuermann EH, Klinger M, Russ G, Pescovitz MD, Prestele H. Polyomavirus BK replication in De Novo Kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013; 13:136–45.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Hirsch HH, Yakhontova K, Lu M, Manzetti J. BK polyomavirus replication in renal tubular epithelial cells is inhibited by Sirolimus, but activated by Tacrolimus through a pathway involving FKBP-12. Am J Transplant. 2016;16:821–32.

    Article  PubMed  CAS  Google Scholar 

  44. Hirsch HH, Randhawa PS, AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13528.

    PubMed  Google Scholar 

  45. Hocker B, Tabatabai J, Schneble L, Oh J, Thiel F, Pape L, Rusai K, Topaloglu R, Kranz B, Klaus G, Printza N, Yavascan O, Fichtner A, Krupka K, Bruckner T, Waldherr R, Pawlita M, Schnitzler P, Hirsch HH, Tonshoff B. JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN registry study. Pediatr Nephrol. 2018;33:2343–52.

    Article  PubMed  Google Scholar 

  46. Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B, Oh J, Zirngibl M, Dello Strologo L, Buscher A, Weber LT, Awan A, Pohl M, Bald M, Printza N, Rusai K, Peruzzi L, Topaloglu R, Fichtner A, Krupka K, Koster L, Bruckner T, Schnitzler P, Hirsch HH, Tonshoff B. Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN registry study. Transplantation. 2019;103:1224–33.

    Article  PubMed  CAS  Google Scholar 

  47. Imlay H, Whitaker K, Fisher CE, Limaye AP. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis. 2018;20:e12928.

    Article  PubMed  Google Scholar 

  48. Kable K, Davies CD, O’Connell PJ, Chapman JR, Nankivell BJ. Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin. Transplant Direct. 2017;3:e142.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Kaur A, Wilhelm M, Wilk S, Hirsch HH. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation. Curr Opin Infect Dis. 2019;32:1–11.

    Article  CAS  Google Scholar 

  50. Kawashima N, Ito Y, Sekiya Y, Narita A, Okuno Y, Muramatsu H, Irie M, Hama A, Takahashi Y, Kojima S. Choreito formula for BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2015;21:319–25.

    Article  PubMed  Google Scholar 

  51. Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009;5:e1000363.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Kenan DJ, Mieczkowski PA, Burger-Calderon R, Singh HK, Nickeleit V. The oncogenic potential of BK-polyomavirus is linked to viral integration into the human genome. J Pathol. 2015;237:379–89.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Knoll GA, Humar A, Fergusson D, Johnston O, House AA, Kim SJ, Ramsay T, Chasse M, Pang X, Zaltzman J, Cockfield S, Cantarovich M, Karpinski M, Lebel L, Gill JS. Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. JAMA. 2014;312:2106–14.

    Article  PubMed  CAS  Google Scholar 

  54. Kuppachi S, Holanda D, Eberlein M, Alexiev B, Tyler AJ, Wissel MC, Kleiboeker SB, Thomas CP. An unexpected surge in plasma BKPyV viral load heralds the development of BKPyV-associated metastatic bladder cancer in a lung transplant recipient with BKPyV nephropathy. Am J Transplant. 2017;17:813–8.

    Article  PubMed  CAS  Google Scholar 

  55. Laskin BL, Denburg M, Furth S, Diorio D, Goebel J, Davies SM, Jodele S. BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:1175–82.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Lautenschlager I, Jahnukainen T, Kardas P, Lohi J, Auvinen E, Mannonen L, Dumoulin A, Hirsch HH, Jalanko H. A case of primary JC polyomavirus infection-associated nephropathy. Am J Transplant. 2014;14:2887–92.

    Article  PubMed  CAS  Google Scholar 

  57. Leboeuf C, Wilk S, Achermann R, Binet I, Golshayan D, Hadaya K, Hirzel C, Hoffmann M, Huynh-Do U, Koller MT, Manuel O, Mueller NJ, Mueller TF, Schaub S, van Delden C, Weissbach FH, Hirsch HH, Study Swiss Transplant Cohort. BK polyomavirus-specific 9mer CD8 T cell responses correlate with clearance of BK viremia in kidney transplant recipients: first report from the Swiss Transplant Cohort Study. Am J Transplant. 2017;17:2591–600.

    Article  PubMed  CAS  Google Scholar 

  58. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood. 2001;98:1971–8.

    Article  PubMed  CAS  Google Scholar 

  59. Li YJ, Weng CH, Lai WC, Wu HH, Chen YC, Hung CC, Yang CW, Tian YC. A suppressive effect of cyclosporine A on replication and noncoding control region activation of polyomavirus BK virus. Transplantation. 2010;89:299–306.

    Article  PubMed  CAS  Google Scholar 

  60. Liacini A, Seamone ME, Muruve DA, Tibbles LA. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation. 2010;90:1450–7.

    Article  PubMed  CAS  Google Scholar 

  61. Limaye AP, Smith KD, Cook L, Groom DA, Hunt NC, Jerome KR, Boeckh M. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant. 2005;5:614–20.

    Article  PubMed  Google Scholar 

  62. Megged O, Stein J, Ben-Meir D, Shulman LM, Yaniv I, Shalit I, Levy I. BK-virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2011;33:190–3.

    Article  PubMed  Google Scholar 

  63. Menter T, Mayr M, Schaub S, Mihatsch MJ, Hirsch HH, Hopfer H. Pathology of resolving polyomavirus-associated nephropathy. Am J Transplant. 2013;13:1474–83.

    Article  PubMed  CAS  Google Scholar 

  64. Miettinen J, Lautenschlager I, Weissbach F, Wernli M, Auvinen E, Mannonen L, Lauronen J, Hirsch HH, Jalanko H. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland. Pediatr Transplant. 2018;23:e13324.

    Article  PubMed  CAS  Google Scholar 

  65. Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen AM, Elgue G, Funke L, Hamad OA, Lonnies H, Magnusson PU, Sanchez J, Teramura Y, Nilsson-Ekdahl K, Ringden O, Korsgren O, Nilsson B, Le Blanc K. Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells. 2012;30:1565–74.

    Article  PubMed  CAS  Google Scholar 

  66. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer. 2010;10:878–89.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Mori Y, Miyamoto T, Kato K, Kamezaki K, Kuriyama T, Oku S, Takenaka K, Iwasaki H, Harada N, Shiratsuchi M, Abe Y, Nagafuji K, Teshima T, Akashi K. Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18:458–65.

    Article  PubMed  Google Scholar 

  68. Mosli HA, Farsi HM, al-Zimaity MF, Saleh TR, al-Zamzami MM. Vesicoureteral reflux in patients with double pigtail stents. J Urol. 1991;146:966–9.

    Article  PubMed  CAS  Google Scholar 

  69. Muller DC, Ramo M, Naegele K, Ribi S, Wetterauer C, Perrina V, Quagliata L, Vlajnic T, Ruiz C, Balitzki B, Grobholz R, Gosert R, Ajuh ET, Hirsch HH, Bubendorf L, Rentsch CA. Donor-derived, metastatic urothelial cancer after kidney transplantation associated with a potentially oncogenic BK polyomavirus. J Pathol. 2018;244:265–70.

    Article  PubMed  CAS  Google Scholar 

  70. Nankivell BJ, Renthawa J, Sharma RN, Kable K, O’Connell PJ, Chapman JR. BK virus nephropathy: histological evolution by sequential pathology. Am J Transplant. 2017;17:2065–77.

    Article  PubMed  CAS  Google Scholar 

  71. Papadimitriou JC, Randhawa P, Rinaldo CH, Drachenberg CB, Alexiev B, Hirsch HH. BK polyomavirus infection and renourinary tumorigenesis. Am J Transplant. 2016;16:398–406.

    Article  PubMed  CAS  Google Scholar 

  72. Papadopoulou A, Gerdemann U, Katari UL, Tzannou I, Liu H, Martinez C, Leung K, Carrum G, Gee AP, Vera JF, Krance RA, Brenner MK, Rooney CM, Heslop HE, Leen AM. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med. 2014;6:242ra83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. Papanicolaou GA, Lee YJ, Young JW, Seshan SV, Boruchov AM, Chittick G, Mommeja-Marin H, Glezerman IG. Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation. Am J Kidney Dis. 2015;65:780–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  74. Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP, Snowden JA, Styczynski J, Yakoub-Agha I, Arat M, Mohty M, Kroger N, Blood European Society for, and Transplantation Marrow. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant. 2019;54:1575.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Pastrana DV, Brennan DC, Cuburu N, Storch GA, Viscidi RP, Randhawa PS, Buck CB. Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathog. 2012;8:e1002650.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Randhawa PS, Finkelstein S, Scantlebury V, Shapiro R, Vivas C, Jordan M, Picken MM, Demetris AJ. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67:103–9.

    Article  PubMed  CAS  Google Scholar 

  77. Randhawa P, Farasati NA, Shapiro R, Hostetler KY. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother. 2006;50:1564–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Reisman L, Habib S, McClure GB, Latiolais LS, Vanchiere JA. Treatment of BK virus-associated nephropathy with CMX001 after kidney transplantation in a young child. Pediatr Transplant. 2014;18:E227–31.

    Article  PubMed  CAS  Google Scholar 

  79. Rinaldo CH, Gosert R, Bernhoff E, Finstad S, Hirsch HH. 1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells. Antimicrob Agents Chemother. 2010;54:4714–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Ringden O, Uzunel M, Sundberg B, Lonnies L, Nava S, Gustafsson J, Henningsohn L, Le Blanc K. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia. 2007;21:2271–6.

    Article  PubMed  CAS  Google Scholar 

  81. Rorije NM, Shea MM, Satyanarayana G, Hammond SP, Ho VT, Baden LR, Antin JH, Soiffer RJ, Marty FM. BK virus disease after allogeneic stem cell transplantation: a cohort analysis. Biol Blood Marrow Transplant. 2014;20:564–70.

    Article  PubMed  Google Scholar 

  82. Schachtner T, Babel N, Reinke P. Different risk factor profiles distinguish early-onset from late-onset BKV-replication. Transpl Int. 2015;28:1081–91.

    Article  PubMed  Google Scholar 

  83. Schaub S, Hirsch HH, Dickenmann M, Steiger J, Mihatsch MJ, Hopfer H, Mayr M. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant. 2010;10:2615–23.

    Article  PubMed  CAS  Google Scholar 

  84. Sester M, Leboeuf C, Schmidt T, Hirsch HH. The “ABC” of virus-specific T cell immunity in solid organ transplantation. Am J Transplant. 2016;16:1697–706.

    Article  PubMed  CAS  Google Scholar 

  85. Shah A, Kumar V, Palmer MB, Trofe-Clark J, Laskin B, Sawinski D, Hogan JJ. Native kidney BK virus nephropathy, a systematic review. Transpl Infect Dis. 2019;21:e13083.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Sharma BN, Li R, Bernhoff E, Gutteberg TJ, Rinaldo CH. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res. 2011;92:115–23.

    Article  PubMed  CAS  Google Scholar 

  87. Sood P, Senanayake S, Sujeet K, Medipalli R, Zhu YR, Johnson CP, Hariharan S. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. Transplantation. 2012;94:814–21.

    Article  PubMed  CAS  Google Scholar 

  88. Spurgeon ME, Lambert PF. Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology. 2013;435:118–30.

    Article  PubMed  CAS  Google Scholar 

  89. Tirindelli MC, Flammia GP, Bove P, Cerretti R, Cudillo L, De Angelis G, Picardi A, Annibali O, Nobile C, Cerchiara E, Dentamaro T, De Fabritiis P, Lanti A, Ferraro AS, Sergi F, Di Piazza F, Avvisati G, Arcese W. Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:1612–7.

    Article  PubMed  CAS  Google Scholar 

  90. Toptas T, Kaygusuz-Atagunduz I, Kani HT, Adiguzel C, Firatli-Tuglular T. Levofloxacin for the treatment of severe refractory BK virus-associated hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: a report of three cases. Oncol Lett. 2014;8:1775–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  91. Tylden GD, Hirsch HH, Rinaldo CH. Brincidofovir (CMX001) inhibits BK polyomavirus replication in primary human urothelial cells. Antimicrob Agents Chemother. 2015;59:3306–16.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  92. Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, Carrum G, Sasa G, Lulla P, Watanabe A, Kuvalekar M, Gee AP, Wu MF, Liu H, Grilley BJ, Krance RA, Gottschalk S, Brenner MK, Rooney CM, Heslop HE, Leen AM, Omer B. Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35:3547–57.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  93. Vu D, Shah T, Ansari J, Naraghi R, Min D. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients. Transplant Proc. 2015;47:394–8.

    Article  PubMed  CAS  Google Scholar 

  94. Wilhelm M, Wilk S, Kaur A, Hirsch HH. Can HLA-B51 protect against BKPyV-DNAemia? Transplantation. 2019;103:e384.

    Article  CAS  Google Scholar 

  95. Wingate JT, Brandenberger J, Weiss A, Scovel LG, Kuhr CS. Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation. Transpl Infect Dis. 2017;19:e12644.

    Article  Google Scholar 

  96. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer. 2005;5:713–25.

    Article  PubMed  CAS  Google Scholar 

  97. Zama D, Masetti R, Vendemini F, Di Donato F, Morelli A, Prete A, Pession A. Clinical effectiveness of early treatment with hyperbaric oxygen therapy for severe late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in pediatric patients. Pediatr Transplant. 2013;17:86–91.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Transplantation & Clinical Virology, Department Biomedicine, University of Basel, Basel, Switzerland

    Fabrice E. Graf & Hans H. Hirsch

  2. Clinical Virology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland

    Hans H. Hirsch

  3. Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland

    Hans H. Hirsch

Authors
  1. Fabrice E. Graf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans H. Hirsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans H. Hirsch .

Editor information

Editors and Affiliations

  1. Miller School of Medicine, University of Miami, Miami, FL, USA

    Michele I. Morris

  2. Massachusetts General Hospital, Harvard University, Boston, MA, USA

    Camille Nelson Kotton

  3. Duke University, Durham, NC, USA

    Camille Wolfe

Section Editor information

  1. Infectious Diseases Division, Harvard University Medical School, Boston, MA, USA

    Camille Nelson Kotton

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Graf, F.E., Hirsch, H.H. (2020). BK Polyomavirus After Solid Organ and Hematopoietic Cell Transplantation: One Virus – Three Diseases. In: Morris, M., Kotton, C., Wolfe, C. (eds) Emerging Transplant Infections. Springer, Cham. https://doi.org/10.1007/978-3-030-01751-4_29-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01751-4_29-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01751-4

  • Online ISBN: 978-3-030-01751-4

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation